Close Menu

NEW YORK (GenomeWeb) – Bruker said today that its board of directors has authorized a new share repurchase program under which it may purchase up to $300 million of its common stock over a two-year period beginning May 14, 2019.

The company will fund the repurchases with cash on hand and funds from its existing credit facility. The authorization does not obligate Bruker to purchase any specific number of shares and may be suspended, modified, or terminated at any time, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.